GRAND: the German retrospective cohort analysis on compliance and persistence and the associated risk of fractures in osteoporotic women treated with oral bisphosphonates

Validity and representativeness of the “Disease Analyzer” patient database for use in pharmaco-epidemiological and pharmacoeconomic studies

(2011) H. Becher et al.   INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS

Oral bisphosphonate compliance and persistence: a matter of choice?

(2010) S. L. Silverman et al.   OSTEOPOROSIS INTERNATIONAL

Compliance and treatment satisfaction of post menopausal women treated for osteoporosis. Compliance with osteoporosis treatment

(2010) Dominique Huas et al.   BMC Womens Health

Impact of Osteoporosis Treatment Adherence on Fracture Rates in North America and Europe

(2009) Ethel S. Siris et al.   AMERICAN JOURNAL OF MEDICINE

Treatment persistence and compliance with a combination of calcium and vitamin D

(2009) C. Castelo-Branco et al.   CLIMACTERIC

Relationship between compliance and persistence with osteoporosis medications and fracture risk in primary health care in France: A retrospective case—control analysis

(2009) François-Emery Cotté et al.   CLINICAL THERAPEUTICS

Poor adherence to oral bisphosphonate treatment and its consequences: a review of the evidence

(2009) Véronique Rabenda et al.   EXPERT OPINION ON PHARMACOTHERAPY

Association of medication attitudes with non-persistence and non-compliance with medication to prevent fractures

(2009) J. T. Schousboe et al.   OSTEOPOROSIS INTERNATIONAL

Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis

(2009) F.-E. Cotté et al.   OSTEOPOROSIS INTERNATIONAL

Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of 101,038 New Bisphosphonate Users

(2008) Jeffrey R Curtis et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Comparison of direct health care costs related to the pharmacological treatment of osteoporosis and to the management of osteoporotic fractures among compliant and noncompliant users of alendronate and risedronate: a population-based study

(2008) J. Blouin et al.   OSTEOPOROSIS INTERNATIONAL

European guidance for the diagnosis and management of osteoporosis in postmenopausal women

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

Comparison of Drug Adherence Rates Among Patients with Seven Different Medical Conditions

(2008) Becky A Briesacher et al.   PHARMACOTHERAPY

Osteoporosis epidemiology update

(2008) Zoe A. Cole et al.   Current Rheumatology Reports